1.57 USD
↘ 0.04 (2.48%)LIVE (AS OF 03:21 PM EDT)
FibroBiologics, Inc. Common Stock
FBLGNASDAQ • USD
Market: OPEN
FBLG is currently priced at $1.57. Our models show a "Neutral" technical signal alongside a "Sell" fundamental rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, FBLG appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 11, 2026.
Open?$1.60
High?$1.83
Low?$1.53
Prev. Close?$1.61
Volume?147.4K
Avg. Volume?304.9K
VWAP?$1.59
Rel. Volume?0.48x
Bid / Ask
Bid?$1.35 × 100
Ask?$1.82 × 100
Spread?$0.47
Midpoint?$1.59
Valuation & Ratios
Market Cap?10.7M
Shares Out?6.7M
Float?5.7M
Float %?86.2%
P/E Ratio?N/A
P/B Ratio?2.31
EPS?-$2.72
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
Themes
Employees
15
Market Cap
10.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-01-31
Address
9350 KIRBY DRIVE
HOUSTON, TX 77054
Phone: 281-671-5150
HOUSTON, TX 77054
Phone: 281-671-5150
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?43
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.63Distress
Confidence?54%Low
Short InterestElevated
Short % of Float?7.21%Elevated
Short Interest?413.7K
Days to Cover?1.4
Free Float5.7M
Avg Daily Volume295.0K
Settlement Date2026-08-31
Financial Health
Current Ratio?2.64Strong
Quick Ratio?2.64Strong
Cash Ratio?1.59Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.31CHEAP▾
Peers100
S&P68
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-391.3%WEAK▾
S&P3
ROA?-228.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-14796000
Enterprise Value?$7.2M
Fundamentals ratios updated end of day